Stephen Evans BA MSc C Stat FRCP (Edin) FISPE
- Room 37b
- LSHTM
- Keppel Street
- London
- WC1E 7HT
- T: +44 (0) 20 7927 2960
- F: +44 (0) 20 7638 2853
My first degree was in physics and chemistry and included a year in the US doing physics and philosophy. Having worked in computing I did the MSc in Medical Statistics at LSHTM and worked in statistics and computing at The London Hospital and Medical College for 25 years. I have also been at the UK Medicines Control Agency and briefly at Quintiles where I mainly worked on the Bristol Royal Infirmary Inquiry. I am a co-opted member of the Pharmacovigilance (Drug Safety) Working Party at the European Medicines Agency and on the WHO Global Advisory Committee on Vaccine Safety. I was President of the International Society of Pharmacoepidemiology for 2010/2011
Affiliation
Teaching
I helped start the short course in pharmacoepidemiology and pharmacovigilance and teach on that course. I also contribute to the DL MSc in Clinical Trials.
Research
Safety of medicines is my major interest. Assessment of safety and risk in a general sense, but particularly in trials and epidemiological studies, especially in databases, are the main topics. I am also interested in scientific fraud and misconduct, especially in clinical trials.
Research areas
- Clinical trials
- Pharmacovigilance
- Risk
- Statistical methods
Disciplines
- Epidemiology
- Pharmacoepidemiology
- Statistics
Other interests
- Patient Safety
-
Selected publications
-
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
Smeeth, L.; Douglas, I.; Hall, A.J.; Hubbard, R.; Evans, S.
British Journal of Clinical Pharmacology, 2009; 67(1):99-109
-
The risk of fractures associated with thiazolidinediones: a self-controlled case-series study
Douglas, I.J.; Evans, S.J.; Pocock, S.; Smeeth, L.
PLoS Med, 2009; 6(9):e1000154
-
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet
Al-Marzouki, S.; Roberts, I.; Evans, S.; Marshall, T.
Lancet, 2008; 372(9634):201-201
-
Novel statistical tools for monitoring the safety of marketed drugs
Almenoff, J.S.; Pattishall, E.N.; Gibbs, T.G.; Dumouchel, W.; Evans, S.J.W.; Yuen, N.
Clinical Pharmacology & Therapeutics, 2007; 82(2):157-166
-
Human Papilloma Virus Immunization in Adolescent and Young Adults: A Cohort Study to Illustrate What Events Might be Mistaken for Adverse Reactions.
Siegrist, C.A.; Lewis, E.M.; Eskola, J.; Evans, S.J.; Black, S.B.;
Pediatr Infect Dis J, 2007; 26(11):979-984
-
Better reporting of harms in randomized trials: An extension of the CONSORT statement
Ioannidis, J. P. A.; Evans, S. J. W.; Gotzsche, P. C.; O'Neill, R. T.; Altman, D. G.; Schulz, K.; Moher, D.
Annals of Internal Medicine, 2004; 141(10):781-8
-
A model for the future conduct of pharmacovigilance
Waller, P. C.; Evans, S. J. W.
Pharmacoepidemiology and Drug Safety, 2003; 12(1):17-19
-
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
Evans, S. J. W.; Waller, P. C.; Davis, S.
Pharmacoepidemiology and Drug Safety, 2001; 10(6):483-486
- → View all Stephen Evans's publications
